These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8990048)

  • 1. Defects of cytochrome c oxidase in the substantia nigra of Parkinson's disease: and immunohistochemical and morphometric study.
    Itoh K; Weis S; Mehraein P; Müller-Höcker J
    Mov Disord; 1997 Jan; 12(1):9-16. PubMed ID: 8990048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
    Wakabayashi K; Takahashi H; Oyanagi K; Ikuta F
    No To Shinkei; 1993 Nov; 45(11):1033-8. PubMed ID: 8135950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study.
    Patt S; Gertz HJ; Gerhard L; Cervós-Navarro J
    Histol Histopathol; 1991 Jul; 6(3):373-80. PubMed ID: 1725760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of the mitochondrial A7237T mutation in Parkinson's disease.
    Lücking CB; Kösel S; Mehraein P; Graeber MB
    Biochem Biophys Res Commun; 1995 Jun; 211(2):700-4. PubMed ID: 7794285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease.
    Hattori N; Tanaka M; Ozawa T; Mizuno Y
    Ann Neurol; 1991 Oct; 30(4):563-71. PubMed ID: 1665052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome c oxidase defects of the human substantia nigra in normal aging.
    Itoh K; Weis S; Mehraein P; Müller-Höcker J
    Neurobiol Aging; 1996; 17(6):843-8. PubMed ID: 9363794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degeneration of the centré median-parafascicular complex in Parkinson's disease.
    Henderson JM; Carpenter K; Cartwright H; Halliday GM
    Ann Neurol; 2000 Mar; 47(3):345-52. PubMed ID: 10716254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease.
    Dexter DT; Sian J; Rose S; Hindmarsh JG; Mann VM; Cooper JM; Wells FR; Daniel SE; Lees AJ; Schapira AH
    Ann Neurol; 1994 Jan; 35(1):38-44. PubMed ID: 8285590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An altered histaminergic innervation of the substantia nigra in Parkinson's disease.
    Anichtchik OV; Rinne JO; Kalimo H; Panula P
    Exp Neurol; 2000 May; 163(1):20-30. PubMed ID: 10785440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
    Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of CKII beta subunits in Lewy bodies of Parkinson's disease.
    Ryu MY; Kim DW; Arima K; Mouradian MM; Kim SU; Lee G
    J Neurol Sci; 2008 Mar; 266(1-2):9-12. PubMed ID: 17884098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.
    Banati RB; Daniel SE; Blunt SB
    Mov Disord; 1998 Mar; 13(2):221-7. PubMed ID: 9539333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra.
    Yamamoto S; Fukae J; Mori H; Mizuno Y; Hattori N
    Neurosci Lett; 2006 Apr; 396(3):187-91. PubMed ID: 16386370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
    Anglade P; Vyas S; Javoy-Agid F; Herrero MT; Michel PP; Marquez J; Mouatt-Prigent A; Ruberg M; Hirsch EC; Agid Y
    Histol Histopathol; 1997 Jan; 12(1):25-31. PubMed ID: 9046040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.
    Hardman CD; Halliday GM; McRitchie DA; Cartwright HR; Morris JG
    Exp Neurol; 1997 Mar; 144(1):183-92. PubMed ID: 9126169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease.
    Mizuno Y; Matuda S; Yoshino H; Mori H; Hattori N; Ikebe S
    Ann Neurol; 1994 Feb; 35(2):204-10. PubMed ID: 8109900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
    Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
    Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.